Literature DB >> 2189890

Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release.

S Bhakdi1, M Muhly, S Korom, G Schmidt.   

Abstract

This study reports on the potent cytocidal and interleukin-1 releasing properties of Escherichia coli hemolysin (ECH) on human monocytes. Nanomolar concentrations of purified ECH (250-2,000 ng/ml) caused rapid and irreversible depletion of cellular ATP to levels below 20% of controls within 60 min. Subcytocidal doses (10-200 ng/ml) of ECH induced rapid release within 60-120 min of large amounts of interleukin 1 beta (IL-1 beta) from cultured monocytes. IL-1 beta release occurred in the presence of actinomycin D and cycloheximide, and was thus probably due to processing and export of intracellular IL-1 beta precursor. Incubation of toxin-producing E. coli at ratios of only 0.3-3 colony-forming units per monocyte evoked approximately 50% depletion of total cellular ATP within 90 min. Toxin producers also stimulated synthesis and release of large amounts of interleukin 1, but not of tumor necrosis factor within the same time span. In contrast, non-toxin producers caused neither cell death nor rapid interleukin 1 release. Stimulation of rapid interleukin 1 release coupled with potent cytocidal effects on cells of monocytic origin may represent pathogenetically significant events incurred by bacterial strains that produce ECH and related cytolysins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189890      PMCID: PMC296636          DOI: 10.1172/JCI114631

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Properties of strains of Escherichia coli isolated from a variety of sources.

Authors:  E M Cooke; S P Ewins
Journal:  J Med Microbiol       Date:  1975-02       Impact factor: 2.472

2.  Hemolysin production as a virulence marker in symptomatic and asymptomatic urinary tract infections caused by Escherichia coli.

Authors:  C Hughes; J Hacker; A Roberts; W Goebel
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

3.  Haemolysin contributes to virulence of extra-intestinal E. coli infections.

Authors:  R A Welch; E P Dellinger; B Minshew; S Falkow
Journal:  Nature       Date:  1981-12-17       Impact factor: 49.962

4.  Hemolysin plasmid coding for the virulence of a nephropathogenic Escherichia coli strain.

Authors:  C Waalwijk; J F van den Bosch; D M MacLaren; J de Graaff
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

5.  Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili.

Authors:  E Blumenstock; K Jann
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

6.  Characterization of pili associated with Escherichia coli O18ac.

Authors:  P Wevers; R Picken; G Schmidt; B Jann; K Jann; J R Golecki; M Kist
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Hemolysin and K antigens in relation to serotype and hemagglutination type of Escherichia coli isolated from extraintestinal infections.

Authors:  D J Evans; D G Evans; C Höhne; M A Noble; E V Haldane; H Lior; L S Young
Journal:  J Clin Microbiol       Date:  1981-01       Impact factor: 5.948

8.  Cytotoxic activity of partially purified Escherichia coli alpha haemolysin.

Authors:  S J Cavalieri; I S Snyder
Journal:  J Med Microbiol       Date:  1982-02       Impact factor: 2.472

9.  Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone.

Authors:  W Lew; J J Oppenheim; K Matsushima
Journal:  J Immunol       Date:  1988-03-15       Impact factor: 5.422

10.  Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection.

Authors:  H J Brooks; F O'Grady; M A McSherry; W R Cattell
Journal:  J Med Microbiol       Date:  1980-02       Impact factor: 2.472

View more
  50 in total

1.  Initial characterization of the hemolysin stachylysin from Stachybotrys chartarum.

Authors:  S J Vesper; M L Magnuson; D G Dearborn; I Yike; R A Haugland
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 2.  The role of immunostimulatory CpG-DNA in septic shock.

Authors:  H Wagner; G B Lipford; H Häcker
Journal:  Springer Semin Immunopathol       Date:  2000

Review 3.  The different hemolysins of Escherichia coli.

Authors:  L Beutin
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

Review 4.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

5.  A cytolysin encoded by Salmonella is required for survival within macrophages.

Authors:  S J Libby; W Goebel; A Ludwig; N Buchmeier; F Bowe; F C Fang; D G Guiney; J G Songer; F Heffron
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.

Authors:  T G Gleason; C W Houlgrave; A K May; T D Crabtree; R G Sawyer; W Denham; J G Norman; T L Pruett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys.

Authors:  D Vagts; H P Dienes; P J Barth; H Ronneberger; K D Hungerer; S Bhakdi
Journal:  Med Microbiol Immunol       Date:  1993-03       Impact factor: 3.402

8.  Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

Authors:  B König; W König
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

Review 9.  The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.

Authors:  Travis J Wiles; Matthew A Mulvey
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

10.  A uropathogenicity island contributes to the pathogenicity of Escherichia coli strains that cause neonatal meningitis.

Authors:  Véronique Houdouin; Stéphane Bonacorsi; Naima Brahimi; Olivier Clermont; Xavier Nassif; Edouard Bingen
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.